CSPC Pharmaceutical-UnspoadrCSPCY
13F holders, Q1 2026 (March 31)2holders
0new positions
0sold out
$4.64avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding CSPC Pharmaceutical-Unspoadr (CSPCY) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($9K) and PNC Financial Services Group, Inc. ($670).
- Company
- CSPC Pharmaceutical-Unspoadr
- Filed as
- 1SPC PHARM ADR (Q1 2026)
- CUSIP
- 12591J207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 1,948 shares sold, net −1,948 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | Reduce -48.8% | 1,965 | $9K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -35.4% | 144 | $670 |
"% of holder's portfolio" is CSPCY's weight in each manager's 13F, not the share of CSPC Pharmaceutical-Unspoadr the manager owns.